These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 20973318

  • 1. Prognostic factors for survival in colorectal cancer patients.
    Laohavinij S, Maneechavakajorn J, Techatanol P.
    J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
    [Abstract] [Full Text] [Related]

  • 2. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S, Ahmad I, Zhu T, Arnold FP, Faiz Anan G, Sami A, Yadav SK, Alvi R, Haider K.
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [Abstract] [Full Text] [Related]

  • 3. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
    Fietkau R, Zettl H, Klöcking S, Kundt G.
    Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
    Wang Y, Zhao P, Wang CF, Shan Y, Zhao DB, Tian YT, Sun YM, Che X, Zhang JW.
    Zhonghua Yi Xue Za Zhi; 2009 Sep 15; 89(34):2381-5. PubMed ID: 20137689
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
    Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi T, Kodaira S, Kato T, Ogawa N.
    Cancer; 1996 Aug 01; 78(3):403-8. PubMed ID: 8697383
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.
    Chir Ital; 2005 Aug 01; 57(5):555-70. PubMed ID: 16241086
    [Abstract] [Full Text] [Related]

  • 10. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul 01; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 11. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Law WL, Ho JW, Chan R, Au G, Chu KW.
    Dis Colon Rectum; 2005 Feb 01; 48(2):218-26. PubMed ID: 15711860
    [Abstract] [Full Text] [Related]

  • 12. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C.
    Colorectal Dis; 2008 Jul 01; 10(6):563-8. PubMed ID: 18070184
    [Abstract] [Full Text] [Related]

  • 13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P, Reyna Huelga A, Labastida Almendaro S, Rodríguez-Coria DF, González Macouzet J, Delgado Gallardo S.
    Rev Invest Clin; 1999 Jul 01; 51(4):205-13. PubMed ID: 10546501
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW, Kim HR, Kim YJ.
    Ann Surg Oncol; 2010 Aug 01; 17(8):2066-72. PubMed ID: 20182809
    [Abstract] [Full Text] [Related]

  • 15. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
    Cai SR, Zheng S, Zhang SZ.
    Zhonghua Zhong Liu Za Zhi; 2005 Aug 01; 27(8):483-5. PubMed ID: 16188146
    [Abstract] [Full Text] [Related]

  • 16. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.
    J Clin Oncol; 2004 May 15; 22(10):1797-806. PubMed ID: 15067028
    [Abstract] [Full Text] [Related]

  • 17. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.
    Am J Clin Oncol; 2008 Feb 15; 31(1):55-63. PubMed ID: 18376229
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].
    He YF, Li YH, Zhang DS, Xiang XJ, Xu RH, Pan ZZ, Zhou ZW, Jiang WQ, He YJ, Wan DS.
    Ai Zheng; 2006 Sep 15; 25(9):1153-7. PubMed ID: 16965661
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S, Nakanisi Y, Taniguchi H, Yamamoto S, Akasu T, Moriya Y, Shimoda T.
    Dis Colon Rectum; 2007 Nov 15; 50(11):1860-6. PubMed ID: 17899273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.